Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

A Prospective Study on the Progression, Recurrence, and Regression of Cervical Lesions: Assessing Various Screening Approaches

Tudor-Catalin Giscă
,
Iulian-Valentin Munteanu
* ,
Ingrid Andrada Vasilache
* ORCID logo ,
Alina-Sinziana Melinte-Popescu
,
Simona-Ruxandra Volovat
,
Ioana Sadyie Scripcariu
,
Raluca Anca Balan
ORCID logo ,
Răzvan Socolov
,
Ioana Pavaleanu
,
Alexandru Carauleanu
,
Constantin Cristian Vaduva
,
Marian Melinte-Popescu
,
Ana-Maria Adam
,
Gigi Adam
,
Petronela Vicoveanu
,
Demetra Socolov
Version 1 : Received: 20 February 2024 / Approved: 21 February 2024 / Online: 21 February 2024 (10:22:09 CET)

A peer-reviewed article of this Preprint also exists.

Gisca, T.; Munteanu, I.-V.; Vasilache, I.-A.; Melinte-Popescu, A.-S.; Volovat, S.; Scripcariu, I.-S.; Balan, R.-A.; Pavaleanu, I.; Socolov, R.; Carauleanu, A.; Vaduva, C.; Melinte-Popescu, M.; Adam, A.-M.; Adam, G.; Vicoveanu, P.; Socolov, D. A Prospective Study on the Progression, Recurrence, and Regression of Cervical Lesions: Assessing Various Screening Approaches. J. Clin. Med. 2024, 13, 1368. Gisca, T.; Munteanu, I.-V.; Vasilache, I.-A.; Melinte-Popescu, A.-S.; Volovat, S.; Scripcariu, I.-S.; Balan, R.-A.; Pavaleanu, I.; Socolov, R.; Carauleanu, A.; Vaduva, C.; Melinte-Popescu, M.; Adam, A.-M.; Adam, G.; Vicoveanu, P.; Socolov, D. A Prospective Study on the Progression, Recurrence, and Regression of Cervical Lesions: Assessing Various Screening Approaches. J. Clin. Med. 2024, 13, 1368.

Abstract

(1) Background: The prediction of cervical lesions evolution is a challenge for clinicians. The prospective study aimed to determine and compare the predictive accuracy of cytology, HPV genotyping, and p16/Ki67 dual staining alone or in combination with personal risk factors for the prediction of progression, regression or persistence of cervical lesions in human papillomavirus (HPV)-infected patients; (2) Methods: This prospective study included HPV-positive patients with or without cervical lesions that underwent follow-up. Descriptive statistics and sensitivity analysis for individual or combined index tests were used for data analysis; (3) Results: The highest predictive performance for the progression of cervical lesions was achieved by a model that comprised a Pap smear suggestive of high-grade squamous intraepithelial lesion (HSIL), the presence of 16/18 HPV strains, a positive p16/Ki67 dual staining result along with the presence of at least 3 clinical risk factors, which had a sensitivity (Se) of 74.42%, a specificity of 97.92%, an area under the receiver operating curve (AUC) of 0.961, and an accuracy of 90.65%. The prediction of cervical lesions regression or persistence was modest; (4) Conclusions: Multiple testing or new biomarkers should be used to improve HPV-positive patient surveillance, especially for cervical lesion regression or persistence prediction.

Keywords

cervical lesions; HPV genotyping; p16/Ki67 dual staining; cervical cytology; clinical risk factors.

Subject

Medicine and Pharmacology, Obstetrics and Gynaecology

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF Download Supplementary

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Supplementary Files Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.